Neisseria meningitidis is a major cause of bacterial septicemia and meningitis. Sequence variation of surface-exposed proteins and cross-reactivity of the serogroup B capsular polysaccharide with human tissues have hampered efforts to develop a successful vaccine. To overcome these obstacles, the entire genome sequence of a virulent serogroup B strain (MC58) was used to identify vaccine candidates. A total of 350 candidate antigens were expressed in Escherichia coli, purified, and used to immunize mice. The sera allowed the identification of proteins that are surface exposed, that are conserved in sequence across a range of strains, and that induce a bactericidal antibody response, a property known to correlate with vaccine efficacy in humans.

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.287.5459.1816DOI Listing

Publication Analysis

Top Keywords

vaccine candidates
8
identification vaccine
4
candidates serogroup
4
serogroup meningococcus
4
meningococcus whole-genome
4
whole-genome sequencing
4
sequencing neisseria
4
neisseria meningitidis
4
meningitidis major
4
major bacterial
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!